CVM Updates
News about Animal Food, Drugs & Devices
These news releases provide the public with relevant and timely information about FDA and animal health. You can receive email updates by subscribing to our email distribution list.
Latest Update
April
- April 9, 2024 - FDA Approves New Antimicrobial Drug for Cattle and Swine
- April 1, 2024 - “Approved by FDA” Labeling Statement Provides Assurance of Safety, Effectiveness of Animal Drugs
March
- March 15, 2024 - FDA Approves Treatment for Yeast Ear Infections in Dogs
- March 13, 2024 - FDA Reminds Veterinarians and Pet Owners about Eye Drop Recalls
- March 8, 2024 - FDA Proposes New Regulations for Animal Drug Labeling
- March 5, 2024 - FDA Accepting Proposals for FY 2024-2025 Funding Opportunities to Collect Data on Antimicrobial Use in Animals
February
- February 28, 2024 - FDA Announces PFAS Used in Grease-Proofing Agents for Food Packaging No Longer Being Sold in the U.S.
- February 26, 2024 - Department of Justice News - Family Dollar Stores LLC Pleads Guilty to Holding Consumer Products under Insanitary Conditions, Agrees to Pay $41.675 Million in Connection with Rodent-Infested Warehouse
- February 22, 2024 - FDA Releases Guidance on Voluntary Premarket Engagement for Foods Derived from Plants Produced Using Genome Editing
- February 16, 2024 - Department of Justice News - Collegeville Man Sentenced to 97 Months in Prison for Scheme to Sell Fraudulent Canine Cancer Drugs to Pet Owners
- February 12, 2024 - Department of Justice News - Covetrus Pleads Guilty to Criminal Misbranding of Veterinary Prescription Drugs
January
December
- December 21, 2023 - FDA Issues Final Guidance to Assist Sponsors of Animal Drugs for Minor Uses and Minor Species (MUMS)
- December 15, 2023 - FDA Seeks Public Input on Guidance for Priority Zoonotic Animal Drug Designation
- December 14, 2023 - Federal Court Enters Consent Decree Against Pharmasol for Distributing Adulterated Drugs
- December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals
- December 7, 2023 - FDA Releases Annual Summary Report on Antimicrobials Sold or Distributed in 2022 for Use in Food-Producing Animals
- December 1, 2023 - FDA Opens Second FY2024 Grant Funding Application Period for Animal Drugs for Minor Uses and Minor Species
November
- November 22, 2023 - Updated - FDA Releases Draft Guidance on Defining Durations of Use for Certain Medically Important Antimicrobial Drugs for Food Animals
- November 17, 2023 - FDA Approves Pregabalin Oral Solution for Alleviating Anxiety Associated with Transportation and Veterinary Visits in Cats
- November 9, 2023 - FDA and CDC Investigate Cases of Salmonella Linked to Pet Food Made by Mid America Pet Food; Multiple Brands Recalled
- November 6, 2023 - Dorothy Bailey to lead FDA’s Office of Minor Use and Minor Species
October
- October 31, 2023 - FDA Proposes Amendments to its Regulation for Prior Notice of Imported Human and Animal Food
- October 24, 2023 - FDA Releases FY 2021 Pesticide Residue Monitoring Report
- October 20, 2023 - FDA Announces FY 2024 Animal Drug User Fee Rates for ADUFA and AGDUFA
- October 12, 2023 - Updated - FDA Advisory: Do Not Feed Certain Lots of Darwin’s Natural Pet Products for Dogs & Cats Due to Salmonella
- October 11, 2023 - Updated October 25, 2023 - FDA Approves First Treatment for Giardia duodenalis in Any Animal Species
- October 2, 2023 - FDA Announces Reauthorization of Animal Drug User Fee Programs
September
- September 27, 2023 - FDA Releases Plan for Supporting Antimicrobial Stewardship in Veterinary Settings for FY 2024-2028
- September 25, 2023 - FDA Releases Draft Guidance on Defining Durations of Use for Certain Medically Important Antimicrobial Drugs for Food Animals
- September 15, 2023 - FDA Supports Innovation in Animal Biotechnology, Veterinary Products, Food for Animals Through New Comprehensive Agenda
- September 14, 2023 - FDA Seeks Public Comment on Guidance Related to Informed Consent for Companion Animal Studies
- September 6, 2023 - FDA Conditionally Approves Phenobarbital Tablets to Control Seizures in Dogs with Idiopathic Epilepsy
August
- August 30, 2023 - Department of Justice News - Justice Department Files Complaint to Enjoin Arizona Company and Its Owner from Manufacturing and Distributing Unapproved Animal Drugs
- August 16, 2023 - FDA Advisory: Do Not Feed Certain Lots of Darwin’s Natural Pet Products for Dogs & Cats Due to Salmonella
- August 2, 2023 - FDA Seeks Public Comment on Possible Framework for Collecting and Analyzing Data on Antimicrobial Use in Food-Producing Animals
July
- July 27, 2023 - FDA Announces FY2024 User Fee Rates Under the Food Safety Modernization Act for the Voluntary Qualified Importer Program and the Accredited Third-Party Certification Program
- July 26, 2023 - Department of Justice News - Thoroughbred Racehorse Trainer Jason Servis Sentenced To Four Years In Prison
- July 13, 2023 - FDA to Participate in National Institutes of Health 2023 Pain in Animals Workshop
- July 13, 2023 - FDA Updates Duration of Enforcement Discretion Policies in Two COVID-19 Era FSMA Guidances
- July 3, 2023 - Update: FDA Animal Drug Safety Communication: FDA provides update on new dosing syringe and training materials for the noise aversion drug Sileo for use in dogs
June
- June 12, 2023 - FDA Announces Transition of Over-the-Counter Medically Important Antimicrobials for Animals to Prescription Status
- June 12, 2023 - Department of Justice News - Midwest Veterinary Supply Sentenced for Misbranding Veterinary Drugs
May
- May 31, 2023 - FDA and European Union Announce Mutual Recognition Agreement for Pharmaceutical Good Manufacturing Practice Inspections of Animal Drugs
- May 24, 2023 - FDA Opening First FY2024 Grant Funding Application Period for Animal Drugs for Minor Uses and Minor Species
- May 16, 2023 - FDA Announces Webinar on Investigational Food Use Authorizations for Genetically Altered Animals
- May 10, 2023 - FDA Announces Project to Provide Key Tool for Animal Biotechnology Developers
- May 5, 2023 - FDA Approves First Monoclonal Antibody for Dogs with Osteoarthritis Pain
- May 1, 2023 - FDA Conditionally Approves First Drug for Anemia in Cats with Chronic Kidney Disease
April
- April 26, 2023 - Department of Justice News - NYC Mother and Son Charged with Interstate Shipment of Misbranded Animal Drugs
- April 6, 2023 - Abbott Recalls the Readers used with the FreeStyle Libre, FreeStyle Libre 14 day, and FreeStyle Libre 2 Flash Glucose Monitoring Systems for Risk of Extreme Heat and Fire
FDA’s Center for Veterinary Medicine is sharing news of this recall to alert veterinarians who may be using this product. - April 5, 2023 - FDA Approves First Generic Flumethasone for Certain Anti-inflammatory Responsive Diseases in Cats, Dogs and Horses
- April 4, 2023 - FDA Releases Draft Guidance on Human User Safety in New Animal Drug Applications
March
- March 31, 2023 - FDA Approves First Generic Maropitant Citrate Tablets for Use in Dogs to Prevent Vomiting
- March 30, 2023 - FDA Approves First Generic Moxidectin Injectable Solution for the Treatment and Control of Parasites in Cattle
- March 29, 2023 - FDA Approves First Generic Cyclosporine Oral Solution for Cats for Treatment of Allergic Dermatitis
- March 28, 2023 - Department of Justice News - Couple Pleads Guilty to Smuggling $2 Million in Pesticides and Veterinary Drugs
- March 28, 2023 - Department of Justice News - Midwest Veterinary Supply Will Forfeit More Than $10 Million
- March 15, 2023 - Updated - FDA Announces Guidance for the Use of Published Literature to Support New Animal Drug Approvals (Español)
- March 9, 2023 - FDA Seeks $7.2 Billion to Protect and Advance Public Health by Enhancing Food Safety and Advancing Medical Product Availability
- March 6, 2023 - Updated - FDA Proposes Revisions to Guidance on Evaluating Safety of Antimicrobial Animal Drugs Based on Their Importance in Human Medicine
February
- February 28, 2023 - FDA Takes Action to Restrict Unlawful Import of Xylazine
- February 22, 2023 - FDA and EPA Announce Virtual Public Meeting and Comment Period on Modernizing their Approach to Oversight of Certain Products for Animals, including Flea and Tick Products
- February 17, 2023 - Tracey Forfa Announced as New Director of FDA’s Center for Veterinary Medicine
- February 15, 2023 - EPA and FDA to Seek Public Input on Modernizing Their Approach to Oversight of Certain Products
January
- January 27, 2023 - Updated - FDA Issues Draft Guidance that Consolidates and Updates Policies on Practices to Prevent Contamination of Animal Food from Unsafe Drug Carryover (Español)
- January 26, 2023 - FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward
- January 20, 2023 - Updated - FDA Cautions Horse Owners Not to Feed Recalled Lots of Top of the Rockies Alfalfa Cubes due to Reports of Illness and Death (Español)
- January 19, 2023 - Updated - FDA Announces Draft Guidance for Heartworm Disease Prevention Products for Dogs (Español)
- January 11, 2023 - FDA Approves First Generic Doramectin Topical Solution for Treatment of Certain Parasites in Cattle (Español)
- January 10, 2023 - FDA Issues the Foreign Supplier Verification Programs for Importers of Food for Humans and Animals Final Guidance